Plantible | $30,000,000 | (Nov 19, 2024)
Theranautilus | $1,200,000 | (Nov 19, 2024)
Bluespine | $7,200,000 | (Nov 19, 2024)
Epigenic Therapeutics
China
- Shanghai
- 30/08/2023
- Series A
- $32,000,000
Epigenic Therapeutics is a frontier biotechnology company dedicated to developing next generation gene editing therapy utilizing regulation of epigenetic genome for a variety of diseases. Founded in 2021 by leading scientists who focus on making novel treatment for serious prevalent and rare diseases. We now have multiple product candidates in the pipeline, including treatment for ocular, neurodegeneration, metabolic, and rare diseases.
- Industry Biotechnology Research
- Website http://www.epigenictx.com/
- LinkedIn https://www.linkedin.com/company/epigenic-therapeutics/about/
Related People
Bob (Bao-Hong) ZhangCo Founder
United States -
San Diego, California
• Visionary and result-orientated R&D leader with medical background and over 20 years of experience in multiple therapeutic areas including metabolic diseases, chronic liver diseases, oncology, inflammation, and CND disorders
• Advanced scientific knowledge and extensive expertise in driving R&D projects at different stages from early drug discovery to IND enabling/filing and early development in biotech, MNC and CRO settings
• Excellent understanding, awareness and experience in the CRO business from both owner and collaborator perspectives, including the importance of value-added core competence development, high performance team building and integration of efficient resources for task delivery
• Demonstrated capability and proved track record in in strategic planning, budgeting, operations and business development in a dynamic environment with high accountability (executive leadership at CRO and founder of a startup, etc.)
• Excellent communication, leadership and interpersonal skills
Zenflow, Inc. | $24,000,000 | (Nov 19, 2024)
Coopah | $1,901,280 | (Nov 19, 2024)
Revisto | $4,000,000 | (Nov 19, 2024)
ChapsVision | $90,000,000 | (Nov 19, 2024)
SuperAnnotate | $36,000,000 | (Nov 19, 2024)
IonKraft | $3,706,797 | (Nov 19, 2024)
ANELLO Photonics | Undisclosed Amount | (Nov 19, 2024)
Influur | $10,000,000 | (Nov 15, 2024)
Naturbeads | $9,890,632 | (Nov 15, 2024)